Precipio Total Current Liabilities 2010-2025 | PRPO
Precipio total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Precipio Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $4 |
| 2023 | $3 |
| 2022 | $4 |
| 2021 | $4 |
| 2020 | $5 |
| 2019 | $4 |
| 2018 | $14 |
| 2017 | $10 |
| 2016 | $3 |
| 2015 | $17 |
| 2014 | $12 |
| 2013 | $9 |
| 2012 | $15 |
| 2011 | $16 |
| 2010 | $8 |
| 2009 | $4 |
| Precipio Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4 |
| 2024-12-31 | $4 |
| 2024-09-30 | $4 |
| 2024-06-30 | $5 |
| 2024-03-31 | $3 |
| 2023-12-31 | $3 |
| 2023-09-30 | $5 |
| 2023-06-30 | $5 |
| 2023-03-31 | $5 |
| 2022-12-31 | $4 |
| 2022-09-30 | $4 |
| 2022-06-30 | $4 |
| 2022-03-31 | $4 |
| 2021-12-31 | $4 |
| 2021-09-30 | $4 |
| 2021-06-30 | $4 |
| 2021-03-31 | $4 |
| 2020-12-31 | $5 |
| 2020-09-30 | $4 |
| 2020-06-30 | $5 |
| 2020-03-31 | $7 |
| 2019-12-31 | $4 |
| 2019-09-30 | $5 |
| 2019-06-30 | $5 |
| 2019-03-31 | $10 |
| 2018-12-31 | $14 |
| 2018-09-30 | $10 |
| 2018-06-30 | $9 |
| 2018-03-31 | $9 |
| 2017-12-31 | $10 |
| 2017-09-30 | $14 |
| 2017-06-30 | $16 |
| 2017-03-31 | $21 |
| 2016-12-31 | $3 |
| 2016-09-30 | $18 |
| 2016-06-30 | $18 |
| 2016-03-31 | $17 |
| 2015-12-31 | $17 |
| 2015-09-30 | $16 |
| 2015-06-30 | $13 |
| 2015-03-31 | $11 |
| 2014-12-31 | $12 |
| 2014-09-30 | $10 |
| 2014-06-30 | $10 |
| 2014-03-31 | $8 |
| 2013-12-31 | $9 |
| 2013-09-30 | $9 |
| 2013-06-30 | $8 |
| 2013-03-31 | $9 |
| 2012-12-31 | $15 |
| 2012-09-30 | $17 |
| 2012-06-30 | $15 |
| 2012-03-31 | $16 |
| 2011-12-31 | $16 |
| 2011-09-30 | $10 |
| 2011-06-30 | $10 |
| 2011-03-31 | $8 |
| 2010-12-31 | $8 |
| 2010-09-30 | $4 |
| 2010-06-30 | $4 |
| 2010-03-31 | $5 |
| 2009-12-31 | $4 |
| 2009-09-30 | $4 |
| 2009-06-30 | $4 |
| 2009-03-31 | $4 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.016B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.136B | 58.95 |
| Hims & Hers Health (HIMS) | United States | $12.000B | 124.67 |
| Tempus AI (TEM) | United States | $10.868B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.592B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.068B | 63.55 |
| Hinge Health (HNGE) | United States | $3.121B | 0.00 |
| Privia Health (PRVA) | United States | $2.805B | 191.75 |
| Enovis (ENOV) | United States | $1.818B | 10.14 |
| Schrodinger (SDGR) | United States | $1.741B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.567B | 0.00 |
| Phreesia (PHR) | United States | $1.501B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 25.86 |
| Azenta (AZTA) | United States | $1.310B | 60.89 |
| 10x Genomics (TXG) | United States | $1.150B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.648B | 0.00 |
| Claritev (CTEV) | United States | $0.605B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.591B | 0.00 |
| Talkspace (TALK) | United States | $0.553B | 165.25 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.353B | 784.00 |
| Outset Medical (OM) | United States | $0.342B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.275B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.130B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.118B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.45 |
| 111 (YI) | China | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |